Fate Therapeutics
在场
高管
查看带有其 13 名主要高管的组织结构图
Fate Therapeutics 搜索最多的简介
- Bob Valamehr, Chief Executive Officer and President
- Shefali Agarwal, Director
- William Rastetter, Chairman of the Board
高管在Fate Therapeutics变化
- Scott Wolchko, Director, President and Chief Executive Officer, Chief Financial Officer, Principal Financial and Accounting Officer, 正在办理退休 (新闻发布的2024十二月2号).
- Bob Valamehr 曾任 President, Research & Development, 将于 20251月1 升职为 Chief Executive Officer and President (新闻发布的2024十二月2号).
- Neely Mozaffarian已作为Director加入公司 (新闻发布的2024八月1号).
创建提醒
跟踪 Fate Therapeutics 的高管变动
生物技术
Fate Therapeutics 拥有 2,335 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Visus Therapeutics and Tenpoint Therapeutics have merged (公布2024十二月27号)..
- Deerfield has announced the acquisition of Singular Genomics (公布2024十二月24号).
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Fate Therapeutics 的最新新闻稿
- Press Releases | Fate Therapeutics, Inc.
- Fate Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Operational Progress | Fate Therapeutics, Inc.
- Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2022 Financial Results | Fate Therapeutics, Inc.
- Fate Therapeutics Announces Expansion of Solid Tumor Collaboration with ONO Pharmaceutical for Off-the-Shelf, iPSC-derived CAR NK and CAR T-Cell Cancer Immunotherapies | Fate Therapeutics, Inc.
- Fate Therapeutics Appoints Brian T. Powl as Chief Commercial Officer | Fate Therapeutics, Inc.
- Fate Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference | Fate Therapeutics, Inc.
- Fate Therapeutics to Present at Upcoming May Investor Conferences | Fate Therapeutics, Inc.
- Fate Therapeutics Reports First Quarter 2022 Financial Results and Highlights Operational Progress | Fate Therapeutics, Inc.
- Fate Therapeutics Announces Publication of FT538 Preclinical Data Demonstrating Enhanced Serial Killing and Functional Persistence without Cytokine Support | Fate Therapeutics, Inc.
- Fate Therapeutics to Present at Upcoming Investor Conferences | Fate Therapeutics, Inc.
- View more press releases Close
通过电子邮件
